Abstract:BACKGROUND:Major depressive disorder (MDD) is a global health challenge that impacts the quality of patients' lives severely. The disorder can manifest in many forms with different combinations of symptoms, which makes its clinical diagnosis difficult. Robust biomarkers are greatly needed to improve diagnosis and to understand the etiology of the disease. The main purpose of this study was to create a predictive model for MDD diagnosis based on peripheral blood transcriptomes.MATERIALS AND METHODS:We collected nine RNA expression datasets for MDD patients and healthy samples from the Gene Expression Omnibus database. After a series of quality control and heterogeneity tests, 302 samples from six studies were deemed suitable for the study. R package "MetaOmics" was applied for systematic meta-analysis of genome-wide expression data. Receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic effectiveness of individual genes. To obtain a better diagnostic model, we also adopted the support vector machine (SVM), random forest (RF), k-nearest neighbors (kNN), and naive Bayesian (NB) tools for modeling, with the RF method being used for feature selection.RESULTS:Our analysis revealed six differentially expressed genes (AKR1C3, ARG1, KLRB1, MAFG, TPST1, and WWC3) with a false discovery rate (FDR) < 0.05 between MDD patients and control subjects. We then evaluated the diagnostic ability of these genes individually. With single gene prediction, we achieved a corresponding area under the curve (AUC) value of 0.63 ± 0.04, 0.67 ± 0.07, 0.70 ± 0.11, 0.64 ± 0.08, 0.68 ± 0.07, and 0.62 ± 0.09, respectively, for these genes. Next, we constructed the classifiers of SVM, RF, kNN, and NB with an AUC of 0.84 ± 0.09, 0.81 ± 0.10, 0.73 ± 0.11, and 0.83 ± 0.09, respectively, in validation datasets, suggesting that the SVM classifier might be superior for constructing an MDD diagnostic model. The final SVM classifier including 70 feature genes was capable of distinguishing MDD samples from healthy controls and yielded an AUC of 0.78 in an independent dataset.CONCLUSION:This study provides new insights into potential biomarkers through meta-analysis of GEO data. Constructing different machine learning models based on these biomarkers could be a valuable approach for diagnosing MDD in clinical practice.

Graph convolutional network with attention mechanism improve major depressive depression diagnosis based on plasma biomarkers and neuroimaging data

DISTINGUISHING BIPOLAR DEPRESSION FROM MAJOR DEPRESSIVE DISORDER USING FNIRS AND DEEP NEURAL NETWORK

Using Dynamic Graph Convolutional Network to Identify Individuals with Major Depression Disorder

Integrating Functional Neuroimaging and Serum Proteins Improves the Diagnosis of Major Depressive Disorder.

Development of Machine-Learning-driven Signatures for Diagnosing and Monitoring Therapeutic Response in Major Depressive Disorder Using Integrated Immune Cell Profiles and Plasma Cytokines

Using Graph Convolutional Network to Characterize Individuals with Major Depressive Disorder Across Multiple Imaging Sites

Multi-Stage Graph Fusion Networks for Major Depressive Disorder Diagnosis

SGMDD: Subgraph Neural Network-Based Model for Analyzing Functional Connectivity Signatures of Major Depressive Disorder.

DepressionGraph: A Two-Channel Graph Neural Network for the Diagnosis of Major Depressive Disorders Using Rs-Fmri

Identifying neuroimaging biomarkers of major depressive disorder from cortical hemodynamic responses using machine learning approaches

Multi-Granularity Graph Convolution Network for Major Depressive Disorder Recognition

Identification of Diagnostic Markers for Major Depressive Disorder Using Machine Learning Methods

The classification of brain network for major depressive disorder patients based on deep graph convolutional neural network

Innovative Neuroimaging Biomarker Distinction of Major Depressive Disorder and Bipolar Disorder through Structural Connectome Analysis and Machine Learning Models

Spatio‐temporal Graph Convolutional Network for Diagnosis and Treatment Response Prediction of Major Depressive Disorder from Functional Connectivity

Sleep Disturbance-Related Neuroimaging Features As Potential Biomarkers for the Diagnosis of Major Depressive Disorder: A Multicenter Study Based on Machine Learning

An adaptive multi-graph neural network with multimodal feature fusion learning for MDD detection

Classification of major depressive disorder using an attention-guided unified deep convolutional neural network and individual structural covariance network

A Multiview Sparse Dynamic Graph Convolution-Based Region-Attention Feature Fusion Network for Major Depressive Disorder Detection

Connectome-based models can predict early symptom improvement in major depressive disorder

Multivariate Machine Learning Analyses in Identification of Major Depressive Disorder Using Resting-State Functional Connectivity: A Multicentral Study